Literature DB >> 18329541

Scleroderma-like fibrosing disorders.

Francesco Boin1, Laura K Hummers.   

Abstract

Many conditions presenting with clinical hard skin and tissue fibrosis can be confused with systemic sclerosis (scleroderma). These disorders have very diverse etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow one to distinguish these conditions from scleroderma and from each other. A prompt diagnosis is important to spare patients from ineffective treatments and inadequate management. This article highlights nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy), eosinophilic fasciitis (Shulman's syndrome), scleromyxedema, and scleredema. These often are detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.

Entities:  

Mesh:

Year:  2008        PMID: 18329541      PMCID: PMC2706095          DOI: 10.1016/j.rdc.2007.11.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  104 in total

1.  Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy.

Authors:  C M Kuldeep; A K Mittal; L K Gupta; V K Paliwal; P Sharma; A Garg
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Jan-Feb       Impact factor: 2.545

2.  Scleredema of Buschke: a report of seven cases.

Authors:  B J Tate; J W Kelly; H Rotstein
Journal:  Australas J Dermatol       Date:  1996-08       Impact factor: 2.875

3.  Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.

Authors:  J M Tabuenca
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis.

Authors:  G I Stables; P C Taylor; A S Highet
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

5.  Scleredema in Chinese patients: a local retrospective study and general review.

Authors:  C S Leung; L Y Chong
Journal:  Hong Kong Med J       Date:  1998-03       Impact factor: 2.227

Review 6.  [Scleredema adultorum Buschke. Case report and review of the literature].

Authors:  A Ulmer; G Schaumburg-Lever; J Bauer; I Kötter; G Fierlbeck
Journal:  Hautarzt       Date:  1998-01       Impact factor: 0.751

7.  Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.

Authors:  Julia C Sansbury; Barbara Cocuroccia; Joseph L Jorizzo; Emanuela Gubinelli; Paolo Gisondi; Giampiero Girolomoni
Journal:  J Am Acad Dermatol       Date:  2004-07       Impact factor: 11.527

8.  In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis.

Authors:  Claire Toquet; Mohamed Amine Hamidou; Karine Renaudin; Anne Jarry; Phryné Foulc; Sébastien Barbarot; Christian Laboisse; Jean-Marie Gilbert Mussini
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

9.  Eosinophilic fasciitis. Increased collagen production and type I procollagen messenger RNA levels in fibroblasts cultured from involved skin.

Authors:  V M Kähäri; J Heino; L Niskanen; J Fräki; J Uitto
Journal:  Arch Dermatol       Date:  1990-05

10.  Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.

Authors:  Heather Richmond; Jeffrey Zwerner; Youn Kim; David Fiorentino
Journal:  Arch Dermatol       Date:  2007-08
View more
  18 in total

Review 1.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

Review 3.  [Scleredema adultorum : Clinical presentation, diagnostic workup, differential diagnosis, treatment option].

Authors:  A Kreuter
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

4.  Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.

Authors:  Catherine Do; Viktor Drel; Chunyan Tan; Doug Lee; Brent Wagner
Journal:  J Invest Dermatol       Date:  2019-04-09       Impact factor: 8.551

Review 5.  Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Authors:  Gustavo Guimarães Moreira Balbi; Ricardo Azêdo Montes; Verônica Silva Vilela; Marcella Azevedo Borges Andrade; Monisa Martins Nóbrega; Luna Azulay-Abulafia; Roberto Souto da Silva; Evandro Mendes Klumb; Roger Abramino Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

6.  Unusual presentation of eosinophilic fasciitis: two case reports and a review of the literature.

Authors:  Ramazan Danis; Sami Akbulut; Abdullah Altintas; Sehmus Ozmen; Cihan Akgul Ozmen
Journal:  J Med Case Rep       Date:  2010-02-08

Review 7.  [Scleroderma and fibrosing diseases].

Authors:  U A Walker; P Knöss; M Jakobs; V Krenn
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

8.  Resolution of pansclerotic morphea after treatment with antithymocyte globulin.

Authors:  Philip Song; Christopher Gocke; Fredrick M Wigley; Francesco Boin
Journal:  Nat Rev Rheumatol       Date:  2009-09       Impact factor: 20.543

9.  Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.

Authors:  Eugenia Rota; Maria Gabriella Nallino; Serena Bainotti; Marco Formica
Journal:  Rheumatol Int       Date:  2009-08-20       Impact factor: 2.631

10.  Face and neck swelling in a 16-year-old boy.

Authors:  Erin Peebles; Chitra Pushpanathan; Syed Pirzada; Paul Dancey
Journal:  BMJ Case Rep       Date:  2012-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.